Aequus Pharmaceuticals Inc (AQS.V)
0.025
0.00 (0.00%)
CAD |
TSXV |
May 31, 16:00
Aequus Pharmaceuticals Total Assets (Quarterly): 1.092M for March 31, 2024
Total Assets (Quarterly) Chart
Historical Total Assets (Quarterly) Data
| Date | Value |
|---|---|
| March 31, 2024 | 1.092M |
| December 31, 2023 | 1.086M |
| September 30, 2023 | 1.172M |
| December 31, 2022 | 1.692M |
| September 30, 2022 | 2.673M |
| June 30, 2022 | 2.588M |
| March 31, 2022 | 3.546M |
| December 31, 2021 | 4.348M |
| September 30, 2021 | 4.609M |
| June 30, 2021 | 4.835M |
| March 31, 2021 | 4.481M |
| December 31, 2020 | 3.135M |
| September 30, 2020 | 3.702M |
| June 30, 2020 | 1.340M |
| March 31, 2020 | 1.478M |
| December 31, 2019 | 1.673M |
| September 30, 2019 | 2.623M |
| June 30, 2019 | 3.143M |
| March 31, 2019 | 1.959M |
| Date | Value |
|---|---|
| December 31, 2018 | 1.996M |
| September 30, 2018 | 2.784M |
| June 30, 2018 | 1.863M |
| March 31, 2018 | 2.252M |
| December 31, 2017 | 2.672M |
| September 30, 2017 | 3.352M |
| June 30, 2017 | 4.547M |
| March 31, 2017 | 5.541M |
| December 31, 2016 | 2.010M |
| September 30, 2016 | 2.989M |
| June 30, 2016 | 1.890M |
| March 31, 2016 | 2.574M |
| December 31, 2015 | 2.430M |
| September 30, 2015 | 1.849M |
| June 30, 2015 | 1.520M |
| March 31, 2015 | 2.441M |
| December 31, 2014 | 3.666M |
| September 30, 2014 | 0.2154M |
| December 31, 2013 | 0.3373M |
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
1.086M
Minimum
Dec 2023
4.835M
Maximum
Jun 2021
2.734M
Average
2.648M
Median
Total Assets (Quarterly) Benchmarks
| Biocure Technology Inc | 1.979M |
| Core One Labs Inc | 7.400M |
| Nova Mentis Life Science Corp | 0.0539M |
| Nanosphere Health Sciences Inc | 0.0238M |
| Lobe Sciences Ltd | 2.109M |
Total Assets (Quarterly) Related Metrics
| Total Liabilities (Quarterly) | 6.040M |
| Shareholders Equity (Quarterly) | -4.948M |
| Debt to Equity Ratio | -1.012 |
| Current Ratio | 0.0865 |
| Net Debt Paydown Yield | -44.88% |